EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Reimbursement of interventional oncology in Australia: How it works and how it does not

Nicholas Brown iD

Journal of Medical Imaging and Radiation Oncology · 2023-12 · 67 (8) · 915-925

DOI: 10.1111/1754-9485.13608 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medical Imaging and Radiation Oncology, online erschienen am 17.12.2023. Verfasst von Nicholas Brown. Beteiligte Einrichtung: The Wesley Hospital, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: National Health Programs, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The practice of interventional oncology (IO) embodies all the qualities that one would expect to find in a modern, value‐based healthcare system. A dynamic, cutting‐edge specialty like IO uses highly‐targeted, minimally‐invasive, image‐guided techniques to deliver cost‐effective, personalised medicine for cancer patients. Unfortunately, the technical and clinical sophistication of IO is not matched by the reimbursement models and funding arrangements in Australia to fully support this critical component of patient care. Differences between state and federal funding lead to inequity of access to ‘standard of care’ interventions for patients across public and private hospitals. IO procedures are poorly represented in the Medicare Benefits Schedule and often inadequately funded to cover the true costs of providing care. Complex private health fund reimbursements and inconsistent rebates for prostheses and essential equipment result in inconsistent access to important services and widely variable out‐of‐pocket costs for patients. IO techniques must be supported by fair, consistent and equitable funding arrangements at all levels to allow for integrated contemporary patient care; only then will the full clinical and economic benefits of IO be realised.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

National Health ProgramsNeoplasmsAgedHumansDelivery of Health CareMedical OncologyAustralia

Stichwörter der Autor:innen

clinical and cost benefiteconomics (medical)non vascular interventional radiologyoncologic imagingvascular interventional radiology

Autor:innen und Institutionen

  • The Wesley Hospital, Brisbane, Queensland, Australia.
  • The University of Queensland, School of Medicine, Brisbane, Queensland, Australia.
  • The Prince Charles' Hospital, Brisbane, Queensland, Australia.

ORCID-Profile: Nicholas Brown

Zitieren

APA

Brown, N. (2023). Reimbursement of interventional oncology in Australia: How it works and how it does not. Journal of Medical Imaging and Radiation Oncology, 67(8), 915-925. https://doi.org/10.1111/1754-9485.13608

Vancouver

Brown N. Reimbursement of interventional oncology in Australia: How it works and how it does not. Journal of Medical Imaging and Radiation Oncology. 2023;67(8):915-925. doi:10.1111/1754-9485.13608

BibTeX
@article{Brown2023,
  author = {Brown, Nicholas},
  title = {Reimbursement of interventional oncology in Australia: How it works and how it does not},
  journal = {Journal of Medical Imaging and Radiation Oncology},
  year = {2023},
  volume = {67},
  number = {8},
  pages = {915--925},
  doi = {10.1111/1754-9485.13608}
}
Kostenlos starten →